| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cc-90011 | lysine-specific histone demethylase 1 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Lymphoma[MeSHID:D008223] |
NA | phase 2 | unknown |
| cc-90011 | lysine-specific histone demethylase 1 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Lymphoma[MeSHID:D008223] |
NA | phase 1 | unknown |
| cc-90011 | lysine-specific histone demethylase 1 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
| cc-90011 | lysine-specific histone demethylase 1 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||